Global Business Travel Group Inc Dossier - Source-backed chat

Global Business Travel Group Inc

GBTGNYSE

SectorConsumer Discretionary

IndustryTravel Services

Beta (adjusted)1.03

Intrinsic Value $6.57median of 3 methodsbased on filings through 30 Jun 2026

Market Price $9.50Price as of 28 Sep 2026

OvervaluedIntrinsic value is 31% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $5B

Enterprise Value $6B

Shares Outstanding 536.1M diluted

Moat Rating None

Next Earnings Date9 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Global Business Travel Group, Inc. (GBTG) is the world's largest B2B corporate travel platform. The company's investment narrative is currently dominated by its definitive agreement, announced on May 2, 2026, to be acquired by Long Lake Management in an all-cash take-private transaction valued at approximately $6.3 billion ($9.50 per share). Because the stock is trading very close to the acquisition price (around $9.36), upside is capped near the buyout price, making 'Hold' the most appropriate recommendation. The transaction is backed by major shareholders representing 69% of GBTG's shares (including American Express, Expedia, QIA, and BlackRock) and is expected to close in the second half of 2026. Long Lake plans to leverage its proprietary Nexus AI platform to accelerate GBTG's technology-enabled service modernization.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets2 analysts · as of 18 Aug 2026

Low · most bearish analyst$9.50

Mean target$9.75

High · most bullish analyst$10.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$6.50

The take-private transaction fails due to unexpected regulatory hurdles, antitrust challenges, or litigation from shareholder investigations regarding the fairness of the $9.50 buyout price. If the deal collapses, the stock could fall back to its pre-announcement trading levels (around $5.50 to $6.50) due to high leverage and execution risks surrounding CWT integration.

Base CaseCentral scenario

$9.75

Matches the consensus mean

The transaction proceeds as planned under the merger agreement. GBTG continues to integrate CWT and roll out its AI-powered Egencia platform while trading in a tight arbitrage band just below the $9.50 buyout price. The deal successfully closes in the second half of 2026.

Bull CaseUpside scenario

$9.50

The take-private transaction closes smoothly in H2 2026, delivering the full $9.50 per share cash consideration to shareholders. Alternatively, a superior competing bid emerges, or regulatory clearances are obtained faster than expected, driving the stock price directly to or slightly above the $9.50 cap.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Compelling take-private valuation of $9.50 per share, representing a 60.2% premium over the pre-announcement closing price.
Strong backing from major shareholders representing 69% of outstanding shares who have entered into voting agreements.
Strategic partnership with Long Lake Management brings advanced applied AI capabilities (Nexus AI) to accelerate digital transformation.
Robust commercial momentum with $3.4 billion in LTM new wins (including Pfizer) and a high 96% customer retention rate.

Key Investment Risks

Arbitrage upside is highly capped as the stock currently trades close to the $9.50 buyout price.
Risk of transaction failure or delay due to regulatory clearances or ongoing shareholder class-action investigations.
Integration and execution risks associated with the massive CWT acquisition if the take-private deal faces unexpected hurdles.
EBITDA margin pressure from rising customer acquisition costs and technology investments, as evidenced by the Q1 2026 EBITDA miss.

Thesis Invalidation Triggers

Termination of the merger agreement by either party.
Regulatory block or significant antitrust delays in key jurisdictions.
Material adverse changes in corporate travel demand or macroeconomic conditions that impact GBTG's underlying business valuation.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.